Clinical Trials Browser

Breast Neoplasms, Uterine Cervical Neoplasms, Lung Neoplasms, Ovarian Neoplasms, Stomach Neoplasms, Endometrial Neoplasms

Stomach Neoplasms

Stomach Neoplasms

Stomach Neoplasms

Stomach Neoplasms

Stomach Neoplasms

Stomach Neoplasms

Stomach Neoplasms

Stomach Neoplasms

Neoplasms, Stomach Neoplasms

Stomach Neoplasms

Stomach Neoplasms

Stomach Neoplasms

Esophageal Neoplasms, Stomach Neoplasms

Stomach Neoplasms

Stomach Neoplasms

Stomach Neoplasms

Bile Duct Neoplasms, Ovarian Neoplasms, Stomach Neoplasms

Stomach Neoplasms

Stomach Neoplasms

Breast Neoplasms, Carcinoma, Carcinoma, Transitional Cell, Lung Neoplasms, Sarcoma, Stomach Neoplasms

Biliary Tract Neoplasms, Pancreatic Neoplasms, Stomach Neoplasms

Stomach Neoplasms

Stomach Neoplasms

Stomach Neoplasms

Stomach Neoplasms

Stomach Neoplasms

Stomach Neoplasms

Stomach Neoplasms

Stomach Neoplasms

Stomach Neoplasms

Stomach Neoplasms

Stomach Neoplasms

Neoplasm Metastasis, Stomach Neoplasms

Adenocarcinoma, Stomach Neoplasms

Stomach Neoplasms

Stomach Neoplasms

Stomach Neoplasms

Stomach Neoplasms

Stomach Neoplasms

Stomach Neoplasms

Stomach Neoplasms

Stomach Neoplasms

Clinical Trials

A Single-arm, Open-label, Multicenter, Phase Ib/II Clinical Trial of CVL237 Tablets in Combination With Serplulimab Injection for the Treatment of Advanced Solid Tumors With PTEN Loss or Low Expression

Megestrol Acetate Oral Suspension for Cachexia in Patients With cStage III Gastric/Gastroesophageal Junction Adenocarcinoma Receiving Neoadjuvant Therapy With Serplulimab Combined With SOX

Huaxi

QL1706-SOX vs SOX Alone as Neoadjuvant Therapy for Resectable Diffuse-Type Gastric Cancer

TNT-SHORT

Conversion Therapy Plus Surgery and Radiotherapy for Retroperitoneal Nodal Metastases in Gastric Cancer

Irinotecan Liposome II + 5-FU/LV + Oxaliplatin + Karelizumab in Neoadjuvant Treatment of Gastric Cancer

Omega-3 Supplementation and Immunotherapy in Gastric Cancer: A Phase II Trial

Phase II Study of QL1706 Combined With Paclitaxel and Bevacizumab for Second-Line Immune Rechallenge in Gastric Cancer

YOUNG-NEOS

Node-Sparing Short-Course Radiotherapy Plus First-Line Therapy and PD-1 Inhibitor in Unresectable/Metastastic pMMR/MSS Gastric Cancer (MODIFI-GC)

A Randomized Controlled Study of Endoscopic Cryoablation Combined With PD-1 Inhibitor for Maintenance Therapy in Advanced Gastric Cancer

Endoscopic Cryoablation Combined With PD-1 in Advanced Gastric Cancer

Efficacy of Tirellizumab Combined With Oral, Intravenous and Abdominal Chemotherapy in Peritoneal Metastatic Gastric/Gastroesophageal Junction Adenocarcinoma

Establishment of Precision Targeted Therapy Strategies for Advanced Gastric Cancer Based on Novel Molecular Subtyping

Use of Pyrvinium to Reverse Stomach Precancerous Conditions

FDZL-GC003

Utidelone Capsule Monotherapy for Patients with Advanced Solid Tumors

Liposomal Irinotecan Combined with Sintilimab for Second-line Treatment of Progressive Gastric Cancer

A Study on the Combination of Sintilimab, Ramucirumab and Chemotherapy for First-line Treatment of Gastric Cancer With Liver Metastasis

Pemigatinib and Immune Checkpoint Inhibitor Treated FGFR1/2/3 Alteration Advanced Solid Tumor

Surufatinib Combined With Serplulimab and Standard Chemotherapy as First-line Treatment in Advanced Solid Tumors With Neuroendocrine Differentiation

Conversion Therapy of Sintilimab in Combination With Fruquintinib and Chemotherapy Versus Sintilimab and Chemotherpay in Stage IV Gastric Cancer

Perioperative Surufatinib Plus Sintilimab Combined With Chemotherapy in Gastric/Gastroesophageal Junction Adenocarcinoma

Phase II Study of Liposomal Irinotecan for Advanced Refractory Gastric Cancer

Multimodal Rehabilitation on Gastric Adenocarcinoma Patients Following Radical D2 Gastrectomy

RC48 Combined With Adebrelimab, Apatinib and S-1 as Neoadjuvant Therapy in Locally Advanced Gastric Cancer

Tislelizumab Combined With Neoadjuvant Chemotherapy Used in the Perioperative Treatment.

Nab-paclitaxel Combined With Cadonilimab (AK104) for the Second-line Treatment of Advanced Gastric Cancer

A Clinical Study of Adebrelimab Combined With Apatinib and Paclitaxel in Patients With Advanced Gastric Cancer.

Cadonilimab Plus CapeOX as First-Line Treatment for Advanced GC/GEJC With High TMEscore

Neoadjuvant Cadonilimab Plus Chemotherapy for Locally Advanced Esophagogastric Junction and Gastric Cancer Trial

EPICURE

A Clinical Study of BioTTT001 in Combination With SOX and Toripalimab in Patients With Gastric Cancer

Efficacy and Safety of Sintilimab Combined With Nab-paclitaxel and Tegio (aTS) as First-line Treatment of Unresectable Locally Advanced, Recurrent or Metastatic Adenocarcinoma of Gastric and Gastroesophageal Junction，a Phase II Clinical Study

Tislelizumab Plus Chemotherapy as Postoperative Adjuvant Therapy in Elderly Patients With LA GC/GEJC

Anlotinib, TQB2450 (PD-L1 Inhibitor), and Albumin-bound Paclitaxel Regimens in the Treatment of GC/GEJA

HIPEC Combined With SOX and Sintilimab in the Treatment of Advanced Gastric Cancer With Peritoneal Metastasis

Clinical Study of Fruquintinib Combined With Sintilimab and XELOX Regimen in the Treatment of Advanced Cancer

SPECTRA

HIPEC Combined With Sintilimab for Gastric Cancer With Peritoneal Metastasis

HIPEC-AS in Patients With Peritoneal Metastasis of the Stomach or Esophagogastric Junction

Indocyanine Green Tracer Using in Laparoscopic Distal Gastrectomy for Early Gastric Cancer